Skip to main content
Ira Jacobson, MD, Gastroenterology, New York, NY, NYU Langone Hospitals

IraJacobsonMD

Gastroenterology • New York, NY

Hepatology & Liver Transplantation

Professor of Medicine, NYU School of Medicine

Join to view full profile

Dr. Jacobson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jacobson's full profile

Already have an account?

Summary

  • Dr. Ira Jacobson is a gastroenterologist in New York, NY and is affiliated with NYU Langone Health and NYU Grossman School of Medicine. He received his medical degree from Columbia University College of Physicians & Surgeons and has been in practice 37 years. He specializes in hepatology & liver transplantation and is experienced in hepatology, viral hepatitides, transplant hepatology, biliary tract disease, and non-alcoholic steatohepatitis.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Gastroenterology, 1982 - 1984
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1981 - 1984
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
  • Yale University
    Yale UniversityB.S., Summa Cum Laude, 1971 - 1975

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1984 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Fellow American College of Physicians
  • Fellow American Gastroenterological Association
  • Fellow American Association for the Study of Liver Diseases
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Diagnosis and Management of Primary Biliary Cholangitis  
    Zobair M Younossi, Kris V Kowdley, Ira M Jacobson, Mitchell L Shiffman, Paul Kwo, Nature
  • Grazoprevir, Ruzasvir, and Uprifosbuvir for HCV After NS5A Treatment Failure  
    Ira Jacobson, MD, Hepatology
  • Hepatitis C virus RNA functionally sequesters miR-122  
    Luna JM, Scheel TK, Danino T, Shaw KS, Mele A, Fak JJ, Nishiuchi E, Takacs CN, Catanese MT, de Jong YP, Rice CM, Darnell RB, Cell, 1/12/2015
  • Join now to see all

Books/Book Chapters

  • Chronic Hepatitis C Virus: Advances in treatment, promise for the future 
    Chapter: Immune modulators and other agents 
    Page 131 - 148with Charles EDEditors: Shiffman ML.Springer, New York2012
  • Clinics in Liver Disease: Hepatobiliary Manifestations of Diseases Involving other Organ Systems 
    Chapter: Cardiovascular disease and the liver 
    Page 1 - 20with Weisberg ISEditors: Hu Ke-Qin.2011
  • Hepatitis C direct acting antivirals: Clinics in Liver Disease: The New Standard of Care 
    Chapter: Telaprevir user’s guide 
    Page 555 - 571with Liapakis A2011
  • Join now to see all

Abstracts/Posters

  • Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naïve patients with chronic hepatitis C virus genotype 1 infection (QUEST-1) a phase 3, random...
    Dore GJ, Foster GR, Fried MW, Radu M, Rafalsky VV, Moroz L, Craxi A, Peeters M, Lenz O, Ouwerkerk-Mahadevan S, De La Rosa G, Kalmeijer R, Scott J, Sinha R, Beaumont-Ma..., Lancet, 1/3/2014
  • Faldaprevir Efficacy in HCV Genotype-1-Infected Patients in Four Phase III Trials: Analysis by Ns3 Baseline Polymorphisms, Genotype-1 Subtype and Genotype-1A Clades
    Berger K, Sarrazin C, Jensen DM, Ferenci P, Dieterich DT, Stern JO, Quinson A, and others, Gastroenterology, 1/1/2014
  • Similar Adjusted Svr12 Rates for HIV Co-Infected and HCV Mono-Infected Patients and No Dose or Population (Treatment-Naïve/Relapser) Effect: Pooled Analysis of Faldapr...
    Dieterich DT, Ferenci P, Negro F, Puoti M, Rockstroh JK, Manns MP, Arastéh K, and others, Gastroenterology, 1/1/2014
  • Join now to see all

Lectures

  • Current State of the Are in HCV Therapy 
    1/1/2015
  • Curren Therapy for HCV 
    Kansas City, KS - 1/1/2015
  • All-Oral Therapies for HCV 
    La Jolla, CA - 1/1/2015
  • Join now to see all

Other

  • Update on hepatitis C virus in HIV/HCV co-infection 
    with Talal AH, National AIDS treatment advocacy program
    http://www.natap.org/2001/jun/current061101.htmwwnatap.org/2001/jun/current061101
    1/1/2001
  • Advice for testing and treatment of hepatitis C 
    with Russo M, Medical Society of the State of New York
    1/1/1999
  • ERCP and the pancreas 
    Jacobson IM, Clinical Advances in Gastroenterology, audiotape update program of American College of Gastroenterol
    1/1/1994

Press Mentions

  • Spring Bank Pharmaceuticals Hosts R&D Day on Pipeline of Novel Immunomodulatory Therapeutics
    Spring Bank Pharmaceuticals Hosts R&D Day on Pipeline of Novel Immunomodulatory TherapeuticsDecember 6th, 2018
  • Ribavirin Beneficial for Patients with Hepatitis C Genotype 3
    Ribavirin Beneficial for Patients with Hepatitis C Genotype 3November 29th, 2018
  • Renowned Liver Disease Specialist Named Director of Hepatology at NYU Langone Health
    Renowned Liver Disease Specialist Named Director of Hepatology at NYU Langone HealthAugust 16th, 2017
  • Join now to see all

Grant Support

  • Placebo-Controlled, Single Ascending Dose Study To Evaluate The Safety, TolerabiNational Center For Research Resources2006

Professional Memberships

Hospital Affiliations

Dr. Ira Jacobson, Dr. Ira Jacobson, MD, Dr. I Jacobson